Organometallics
Article
2+4
2
1+3
159.4 (ps t,
J
= 3.0 Hz, 2,6-py), 219.1 (t, JC−P = 5 Hz, CO).
PtCH), 30.0 (s, CH3), 45.8 (ps t,
J
= 16.9 Hz, PCH2), 123.2
C−P
C−P
3+5
1+3
31P NMR (101.25 MHz, CD2Cl2): 2a, δ 28.1 (s, 1JP−Pt = 2851 Hz); 2b,
δ 20.8 (s, JP−Pt = 3252 Hz). IR ν
(ps t,
126.8 (ps t,
J
= 5.1 Hz, 3,5-py), 126.5 (ps t,
J
= 28.8 Hz, Phi),
C−P
C−P
1+3
3+5
(cm−1): 2a,b, 1626 (m, CO),
1
J
= 28.5 Hz, Phi′), 129.4 (ps t,
J
= 5.6 Hz,
̃
C−P
C−P
3+5
Phm), 129.5 (ps t,
(s, Php′), 133.2 (ps t,
J
= 5.6 Hz, Phm′), 132.3 (s, Php), 132.6
= 6.1 Hz, Pho), 133.9 (ps t,
1639 (m, CO).
C−P
2+4
2+4
J
J
=
=
[Pt(PNP){CH2C(O)(CH2)3CH3}]BF4 (3a) and [Pt(PNP){C(O)-
(CH2)4CH3}]BF4 (3b). Yield (combined): 268 mg (0.313 mmol,
91%). Anal. Calcd for C37H38BF4NOP2Pt·(CH3CH2)2O: C, 52.91;
H, 5.20; N, 1.51. Found: C, 52.52; H, 5.29; N, 1.71. 1H NMR
(500 MHz, CD3NO2): 3a, δ (CH2CH2CH2CH3 are hidden under the
C−P
C−P
2+4
2
7.1 Hz, Pho′), 140.6 (s, 4-py), 159.5 (ps t,
J
= 3.0 Hz, JC−Pt
C−P
33 Hz, 2,6-py), 212.1 (s, CO). 31P NMR (101.25 MHz, CD2Cl2):
1
δ 28.7 (s, JP−Pt = 3006 Hz).
[Pt(PNP){CH(CH3)C(O)CH2CH2CH3}]BF4 (7a) and [Pt(PNP){CH-
(CH2CH2CH3)C(O)CH3}]BF4 (7b). Yield (combined): 262 mg (0.306
mmol, 89%). Mp: 251 °C dec. Anal. Calcd for C37H38BF4-
NOP2Pt·(CH3CH2)2O: C, 52.91; H, 5.20; N, 1.51. Found: C, 52.90;
3
2
signals of 3b) 2.94 (t, 2H, JH−P = 6.3 Hz, JH−Pt = 110 Hz, PtCH2),
4.64 (ps t, 4H, 2+4JH−P = 4.6 Hz, PCH2), 7.59−7.68 (m, 12H, Ph), 7.74
3
(d, 2H, JH−H = 7.5 Hz, 3,5-py), 7.86−7.90 (m, 8H, Ph), 8.06 (t, 1H,
1
3JH−H = 7.5 Hz, 4-py); 3b, δ 0.63 (t, 3H, JH−H = 7.3 Hz, CH3), 0.76
3
H, 5.30; N, 1.66. H NMR (500 MHz, CD3NO2): 7a, δ 0.57 (t, 3H,
3
3
3JH−H = 9.1 Hz, CH3), 0.88 (d, 3H, JH−H = 8.2 Hz, JH−Pt = 57 Hz,
PtCCH3), 1.05 (m, 2H, CH2), 1.71 (m, 1H, OCCHaHb), 1.93
(m, 1H, OCCHaHb), 3.35 (m, 1H, 3JH−H = 8.2 Hz, 3JH−Pt = 148 Hz,
PtCH), 4.56 (d ps t, 2H, 3JH−H = 22.1 Hz, 2+4JH−P = 5.8 Hz, PCHaHb),
(m, 2H, CH2), 0.93 (m, 2H, CH2), 1.09 (m, 2H, CH2), 2.16 (t, 2H,
3JH−H = 7.5 Hz, COCH2), 4.70 (ps t, 4H,
J
= 4.8 Hz, PCH2),
2+4
H−P
3
7.59−7.68 (m, 12H, Ph), 7.74 (d, 2H, JH−H = 7.5 Hz, 3,5-py), 7.86−
7.90 (m, 8H, Ph), 8.06 (t, 1H, JH−H = 7.5 Hz, 4-py). 13C NMR
3
3
2+4
4.71 (d ps t, 2H, JH−H = 22.1 Hz,
J
= 5.6 Hz, PCHaHb),7.59−
H−P
(100.61 MHz, CD2Cl2): 3a, δ (CH3 not observed or overlapped by 3b
signal at 13.6), 14.2 (s, PtCH2), 22.1 (s, CH2), 26.1 (s, CH2), 43.1 (s,
7.72 (m, 14H, Ph, 3,5-py), 7.85−8.25 (m, 9H, Ph, 4-py); 7b, δ 0.48 (t,
3
1+3
3+5
3H, JH−H = 9.1 Hz, CH3), 0.55−2.50 (signals for CH2CH2 and O
CH2), 45.9 (ps t,
J
= 16.9 Hz, PCH2), 123.1 (ps t,
J
=
=
C−P
C−P
5.5 Hz, 3,5-py), 126.6 (ps t, 2+4JC−P = 29.7 Hz, Phi), 129.5 (ps t, 3+5JC−P
CCH3 overlapped by signals of 7a), 3.31 (m, 1H, PtCH), 4.52−4.76
(signals for 4H of PCHaHb overlapped by signals of 7a), 7.59−7.72
5.5 Hz, Phm), 132.6 (s, Php), 133.3 (ps t, 2+4JC−P = 6.8 Hz, Pho), 140.5
(s, 4-py), 160.2 (ps t, 2+4JC−P = 3.0 Hz, 2,6-py), 214.9 (s, CO); 3b, δ
(m, 14H, Ph, 3,5-py), 7.85−8.25 (m, 9H, Ph, 4-py). 13C NMR (100.62
3
MHz, CD2Cl2): 7a, δ 13.2 (s, CH3), 18.2 (s, CH2), 16.8 (t, JC−P
=
=
4
13.6 (s, CH3), 22.2 (s, CH2), 23.5 (s, JC−Pt = 18 Hz, CH2), 31.1 (s,
3
2
1
2 Hz, JC−Pt = 33 Hz, PtCHCH3), 22.5 (t, JC−P = 3 Hz, JC−P
1+3
3
CH2), 45.1 (ps t,
J
= 17.3 Hz, PCH2), 58.3 (t, JC−P = 3.8 Hz,
C−P
579 Hz, PtCH), 45.2 (ps t, 1+3JC−P = 17.1 Hz, PCH2), 45.4 s (s, CH2),
2JC−Pt = 188 Hz, COCH2), 123.0 (ps t, JC−P = 5.3 Hz, 3,5-py), 127.7
3+5
1+3
123.1 (ps t,
J
= 4.8 Hz, 3,5-py), 127.5 (ps t,
J
= 28.7 Hz,
3+5
C−P
C−P
(ps t, JC−P = 29.0 Hz, Phi), 129.6 (ps t,
J
= 5.7 Hz, Phm), 132.4
Phi), 127.8 (ps t, 1+3JC−P = 28.5 Hz, Phi′), 129.5 (ps t, 3+5JC−P = 5.5 Hz,
C−P
(s, Php), 133.0 (ps t, 2+4JC−P = 6.8 Hz, Pho), 140.9 (s, 4-py), 159.4 (ps
3+5
Phm), 129.6 (ps t,
J
= 5.5 Hz, Phm′), 132.4 (s, Php), 132.9 (s,
2+4
4
2
C−P
t,
J
= 3.0 Hz, JC−Pt = 33 Hz, 2,6-py), 218.1 (t, JC−P = 5.0 Hz,
Php′), 133.5 (ps t, 2+4JC−P = 6.1 Hz, Pho), 134.7 (ps t, 2+4JC−P = 7.2 Hz,
Pho′), 140.7 (s, 4-py), 160.2 (ps t, 2+4JC−P = 3.0 Hz, 2JC−Pt = 33 Hz, 2,6-
C−P
CO). 31P NMR (161.92 MHz, CD2Cl2): 3a, δ 28.2 (s, 1JP−Pt = 2866
1
Hz); 3b, δ 20.5 (s, JP−Pt = 3271 Hz).
py), 215.2 (s, CO); 7b, δ 13.5 (s, CH3), 22.7 (s, PtCH), 24.3 (s,
= 17.0 Hz,
C−P
[Pt(PNP)(CCC6H5)]BF4 (4). Yield: 230 mg (0.268 mmol, 78%).
1+3
CH2), 30.1 (s, CH3), 34.5 (s, CH2), 45.1 (ps t,
J
Mp: 277 °C dec. Anal. Calcd for C39H32BF4NP2Pt: C, 54.56; H, 3.76;
3+5
1+3
PCH2), 123.2 (ps t,
J
= 4.8 Hz, 3,5-py), 127.3 (ps t,
J
=
N, 1.63. Found: C, 53.77; H, 4.16; N, 1.65.46 1H NMR (250 MHz,
C−P
C−P
1+3
28.8 Hz, Phi), 127.7 (ps t,
J
= 28.4 Hz, Phi′), 129.3 (ps t,
C−P
2+4
CD2Cl2): δ 4.63 (ps t, 4H,
J
= 5.0 Hz, PCH2), 7.08−7.23
H−P
3
3+5
3+5
J
= 5.4 Hz, Phm), 129.8 (ps t,
J
= 5.3 Hz, Phm′), 132.5
C−P
C−P
(m, 5H, CPh), 7.54−7.63 (m, 12H, Ph), 7.84 (d, 2H, JH−H = 7.6 Hz,
(s, Php), 132.8 (s, Php′), 133.6 (ps t, 2+4JC−P = 6.2 Hz, Pho), 134.6 (ps t,
3
3,5-py), 7.98−8.07 (m, 8H, Ph), 8.13 (t, 1H, JH−H = 7.6 Hz, 4-py).
2+4
2+4
J
= 7.1 Hz, Pho′), 140.8 (s, 4-py), 160.1 (ps t,
J
= 3.0 Hz,
C−P
C−P
13C NMR (100.62 MHz, CD2Cl2): δ 43.9 (ps t,
J
= 16.9 Hz,
1+3
2,6-py), 212.0 (s, CO). 31P NMR (161.92 MHz, CD2Cl2): 7a,
C−P
2
1
PCH2), 75.9 (t, JC−2 P = 13.5 Hz, JC−Pt = 1325 Hz, PtCC), 114.5
1
1
δ 28.9 (s, JP−Pt = 3031 Hz); 7b, 29.4 (s, JP−Pt = 3026 Hz).
NMR Studies of Complexes 1, 2a,b, and 6 in Solution. To a
solution of 10 mg (0.011 mmol) of complex 1 in 0.5 mL of CD2Cl2
(a) 3 drops (∼ 30 mg, ∼ 0.18 mmol) and (b) 1 drop (∼ 10 mg, ∼
3
3+5
(t, JC−P = 3.0 Hz, JC−Pt = 372 Hz, PtCC), 123.5 (ps t,
J
=
=
C−P
5.8 Hz, 3,5-py), 126.6 (s, C6H5), 126.9 (s, C6H5), 127.5 (ps t, 1+3JC−P
3+5
30.0 Hz, Phi), 128.0 (s, C6H5), 129.5 (ps t,
131.1 (s, C6H5), 132.4 (s, Php), 133.1 (ps t,
J
= 5.8 Hz, Phm),
= 7.0 Hz, Pho),
C−P
2+4
J
1
C−P
0.062 mmol) of HBF4·Et2O (54% HBF4 in Et2O) were added. A H
2+4
2
141.1 (s, 4-py), 161.8 (ps t,
J
= 3.8 Hz, JC−Pt = 34 Hz, 2,6-py).
C−P
NMR spectrum was recorded of each respective solution.
To a solution of 10 mg of complex 1 in 0.5 mL of CD2Cl2
successively 5−200 μL portions (3−600 equiv) of HBF4·Et2O were
added. After each 5 μL (for the first 50 μL) and after 100, 150, and
200 μL were added to the solution, a 31P NMR spectrum was
recorded.
31P NMR (101.25 MHz, CD2Cl2): δ 22.5 (s, JP−Pt = 2576 Hz).
1
IR ν
̃
(cm−1): 1055 (vs, BF4), 2125 (m, CC).
[Pt(PNP){CCC(CH3)3}]BF4 (5). Yield: 222 mg (0.265 mmol, 77%).
Mp 238 °C (decomposition). Anal. Calcd for C37H36BF4NP2Pt: C,
53.00; H, 4.33; N, 1.67. Found: C, 51.63; H, 4.28; N, 1.67.46 1H NMR
2+4
(250 MHz, CD2Cl2): δ 1.16 (s, 9H, C4H9), 4.56 (ps t, 4H,
J
=
H−P
To the respective solutions of 10 mg of complexes 1, 2a,b, and 6 in
5.0 Hz, PCH2), 7.54−7.61 (m, 12H, Ph), 7.80 (d, 2H, 3JH−H = 7.7 Hz,
1
0.5 mL of CD2Cl2 a few drops of concentrated HCl were added. H
3
and 31P NMR spectra were recorded of each solution.
3,5-py), 7.95−8.04 (m, 8H, Ph), 8.11 (t, 1H, JH−H = 7.7 Hz, 4-py).
13C NMR (100.62 MHz, CD2Cl2): δ 29.6 (s, JC−Pt = 18 Hz,
3
1+3
C(CH3)3), 31.9 (s, C(CH3)3), 43.81 (ps t,
J
= 16.8 Hz, PCH2),
C−P
ASSOCIATED CONTENT
2
1
■
59.2 (t, JC−P = 16.8 Hz, JC−Pt = 1299 Hz, PtCC), 123.4 (ps t,
3+5
3
2
J
= 5.7 Hz, 3,5-py), 124.5 (t, JC−P < 3 Hz, JC−Pt = 363 Hz,
S
* Supporting Information
C−P
2+4
3+5
Figures giving the H,1H COSY NMR spectrum of complex 1,
1
PtCC), 128.0 (ps t,
J
= 30.0 Hz, Phi), 129.3 (ps t,
J
=
C−P
C−P
1H and 31P NMR spectra of complex 1 and HBF4·Et2O added,
5.8 Hz, Phm), 132.2 (s, Php), 133.2 (ps t, JC−P = 6.9 Hz, Pho), 140.8
2+4
2
(s, 4-py), 161.7 (ps t,
J
= 3.7 Hz, JC−Pt = 38 Hz, 2,6-py).
1
C−P
a
31P NMR data plot of Table 3, and H, 13C, and 31P NMR
31P NMR (101.25 MHz, CD2Cl2): δ 20.2 (s, JP−Pt = 2617 Hz). IR ν
̃
1
spectra of complexes 4 and 5, and a CIF file and table giving
crystallographic data and refinement details for complexes 1
and 2b. This material is available free of charge via the Internet
(cm−1): 1051 (vs, BF4), 2123 (w, CC).
[Pt(PNP){CH(CH3)C(O)CH3}]BF4 (6). Yield: 242 mg (0.292 mmol,
85%). Mp: 244 °C dec. Anal. Calcd for C35H34BF4NOP2Pt·0.5-
(CH3CH2)2O: C, 51.34; H, 4.54; N, 1.62. Found: C, 51.31; H, 4.81;
N, 1.72. 1H NMR (250 MHz, CD2Cl2): δ 0.85 (d, 3H, 3JH−H = 6.6 Hz,
3JH−Pt = 50.5 Hz, CH3), 1.48 (s, 3H, JH−Pt = 11.0 Hz, CH3), 3.28
4
AUTHOR INFORMATION
■
(q, 1H, 3JH−H = 6.8 Hz, 2JH−Pt = 117 Hz, PtCH), 4.47 (m, 4H, PCH2),
7.53−8.04 (m, 23H, Ph, py). 13C NMR (100.62 MHz, CD2Cl2): δ 17.1
(s, 3JC−Pt = 34 Hz, PtCHCH3), 23.1 (t, 2JC−P = 3.0 Hz, 1JC−Pt = 578 Hz,
Corresponding Author
6455
dx.doi.org/10.1021/om2007908|Organometallics 2011, 30, 6446−6457